MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
US Patent 8,030,280
Filed on 2010-08-06
Filed on 2010-08-06
MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES
Japan
2009-519525
Filed on 2009-01-13
2009-519525
Filed on 2009-01-13
Vaccines for B Cell Malignancies
Canada
2246708
Filed on 1997-02-13
2246708
Filed on 1997-02-13
Mutated Pseudomonas Exotoxins with Reduced Antigenicity
European Patent
10179539.1
Filed on 2006-07-25
10179539.1
Filed on 2006-07-25
Mutated Pseudomonas Exotoxins with Reduced Antigenicity
European Patent
10179520.1
Filed on 2006-07-25
10179520.1
Filed on 2006-07-25
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ESPHAGEAL ADENOCARCINOMAS
European Patent
08838376.5
Filed on 2008-10-10
08838376.5
Filed on 2008-10-10
Biologically Active Macrolides, Compositions, and Uses Thereof
US Patent 8,741,947
Filed on 2010-08-06
Filed on 2010-08-06
MELANOMA ANTIGENS
European Patent
10010559.2
Filed on 1995-04-21
10010559.2
Filed on 1995-04-21
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
European Patent
10010354.8
Filed on 2001-01-26
10010354.8
Filed on 2001-01-26
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
European Patent
10010389.4
Filed on 2001-01-26
10010389.4
Filed on 2001-01-26